Dr. Haywood Brown discusses redefining what constitutes postpartum care during the fourth trimester.
Although the development of a PPD medication is commendable, Dr. Yonkers also notes there are several hurdles which need to be addressed.
In the United States, the Edinburgh Postnatal Depression Scale (EPDS) is the validated screening tool for postpartum depression most commonly used in current clinical practice.
Ob/gyns, support staff, and patients all need to be educated about the needs of the mother/child dyad during the “fourth trimester.”
An analog of an endogenous human hormone has been approved as treatment, but it comes with a steep price tag.
Referral for counseling is key for women at risk.
Women with behavioral conditions need ongoing care through pregnancy and postpartum, but our health care system makes this a challenge
Postpartum hemorrhage (PPH) is one of the most common life-threatening emergency encountered by obstetricians. Test your knowledge and ability to recognize signs in a patient.
A meta-analysis of 140 studies by investigators from the Cochrane Collaboration shows that oxytocin may not be the best choice for prevention of postpartum hemorrhage, despite the current recommendation from the World Health Organization (WHO). PLUS: Commentary on the findings from our Maternal Mortality Series Editor, Carolyn Zelop, MD.
Results of a recent extended study of prolapse surgery showed that in 60% of women, two common procedures failed within 5 years, but patients still reported a higher quality of life than before the surgery. Plus: ACOG has released a revised Committee Opinion to emphasize the idea of the “fourth trimester” in an attempt to reduce maternal morbidity and mortality numbers. Also: A recent study suggests that entering menopause later in life may be associated with a small boost in memory performance years later.